Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Translation from Preclinical Research to Clinical Trials: Brain-Gut Photobiomodulation Therapy for Alzheimer’s Disease

The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis

11th Clinical Trials on Alzheimer’s Disease (CTAD) 2018, Barcelona

Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Guillaume J. Blivet, Jacques Touchon.

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.